Tacey Goss completes Series C Financing for Tosk, Inc.
18/9/2007-
Tacey Goss completes Series C Financing for Tosk, Inc. Tosk is a bio medical research company that holds a patented drug screening method that allows it to screen compounds that may reduce or even eradicate side effects of current toxic therapeutic drugs. Tacey Goss acts as its corporate and securities counsel and is pleased to announced that Tosk closed its Series C Financing in February, 2007 for a total aggregate of $6.5 Million.
News